Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Annovis Bio, Inc.

ANVS Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of ANVS by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
ANVS Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
ANVS Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
ANVS Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in ANVS holdings by institutional investors

Quarterly net insider trading by ANVS's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for ANVS

Quiver Logo

No former government officials on record as having lobbied for ANVS

Revolving Door Dashboard

ANVS Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

ANVS Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
ANVS Income Statement
ANVS Balance Sheet
ANVS Cash Flow
U.S. Patents

New ANVS patent grants

  • Patent Title: Inhibition of neurological injuries due to infections via administration of butanetap and analogs thereof Mar. 24, 2026
  • Patent Title: Prevention or of disease states due to metal dis-homeostasis via administration of posiphen to healthy or sick humans Aug. 19, 2025
  • Patent Title: (3ar)-1,3a,8-trimethyl-1,2,3,3a,8,8ahexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegeneration Nov. 19, 2024
  • Patent Title: Methods of treatment or prevention of acute brain or nerve injuries Jul. 23, 2024
  • Patent Title: Prevention or treatment of disease states due to metal dis-homeostasis via administration of posiphen to healthy or sick humans Mar. 07, 2023
  • Patent Title: (3ar)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegeneration Aug. 02, 2022
  • Patent Title: (3ar)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegeneration Jul. 12, 2022
  • Patent Title: (3ar)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegeneration Jul. 05, 2022
  • Patent Title: (3ar)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegeneration Aug. 24, 2021
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to ANVS from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
ANVS News

Recent insights relating to ANVS

CNBC Recommendations

Recent picks made for ANVS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ANVS

ANVS Analyst Ratings

ANVS Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
ANVS Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $ANVS stock a Buy, Sell, or Hold?

  • What is the price target for $ANVS stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

ANVS Top Shareholders
Shareholder
Shares Held
ANVS Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $ANVS stock?

  • Who owns the most shares of $ANVS stock?

  • What funds own $ANVS stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

ANVS Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view ANVS Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About ANVS

Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.

  • Address Malvern, PA
  • Market Cap 56.8 million
  • Employees 7
  • Industrial Classification Pharmaceutical Preparations

Annovis Bio, Inc. (ANVS) Historical Stock Prices

Annovis Bio, Inc. (ANVS) closed at $1.33 on September 24, 2026. Over the past year its adjusted close ranged from $1.04 to $5.10. Daily prices go back to January 6, 2014, 1,710 trading days in all.

  • 1 month-26.92%
  • 3 months-19.39%
  • Year to date-61.56%
  • 1 year-39.27%
  • 3 years-86.09%
  • 5 years-96.14%
  • Max+3,225.00%
See every congressional and insider trade on the ANVS price chart

Quiver Premium charts ANVS's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 24, 2026 1.27 1.34 1.23 1.33 1.33 855,174
Sep 23, 2026 1.30 1.33 1.24 1.27 1.27 1,145,513
Sep 22, 2026 1.19 1.30 1.19 1.26 1.26 1,214,829
Sep 21, 2026 1.16 1.22 1.16 1.19 1.19 885,901
Sep 18, 2026 1.12 1.16 1.09 1.14 1.14 681,977
Sep 17, 2026 1.10 1.17 1.08 1.10 1.10 1,522,834
Sep 16, 2026 1.12 1.13 1.04 1.04 1.04 1,432,807
Sep 15, 2026 1.14 1.14 1.10 1.12 1.12 824,332
Sep 14, 2026 1.10 1.17 1.09 1.14 1.14 1,201,834
Sep 11, 2026 1.20 1.23 1.10 1.12 1.12 1,894,431
Sep 10, 2026 1.21 1.26 1.17 1.19 1.19 1,338,021
Sep 9, 2026 1.31 1.32 1.22 1.22 1.22 1,747,759
Sep 8, 2026 1.39 1.40 1.30 1.30 1.30 1,963,309
Sep 4, 2026 1.40 1.44 1.38 1.39 1.39 1,532,941
Sep 3, 2026 1.65 1.68 1.32 1.38 1.38 7,332,095
Sep 2, 2026 1.71 1.76 1.69 1.70 1.70 606,825
Sep 1, 2026 1.73 1.73 1.67 1.69 1.69 457,632
Aug 31, 2026 1.72 1.78 1.70 1.72 1.72 425,505
Aug 28, 2026 1.78 1.83 1.71 1.72 1.72 504,513
Aug 27, 2026 1.76 1.81 1.76 1.81 1.81 301,972
Aug 26, 2026 1.84 1.86 1.76 1.78 1.78 235,712
Aug 25, 2026 1.76 1.82 1.76 1.82 1.82 560,283
Aug 24, 2026 1.83 1.83 1.74 1.75 1.75 670,723
Aug 21, 2026 1.78 1.84 1.77 1.82 1.82 618,557
Aug 20, 2026 1.84 1.89 1.78 1.79 1.79 548,818
Aug 19, 2026 1.90 1.90 1.79 1.85 1.85 746,906
Aug 18, 2026 1.75 1.82 1.74 1.80 1.80 449,498
Aug 17, 2026 1.82 1.85 1.74 1.74 1.74 661,966
Aug 14, 2026 1.83 1.90 1.80 1.85 1.85 949,713
Aug 13, 2026 1.84 1.86 1.75 1.79 1.79 712,425
Aug 12, 2026 1.87 1.90 1.80 1.80 1.80 502,307
Aug 11, 2026 1.91 1.91 1.85 1.89 1.89 351,675
Aug 10, 2026 1.90 1.90 1.85 1.89 1.89 321,131
Aug 7, 2026 1.90 1.95 1.85 1.88 1.88 557,276
Aug 6, 2026 1.91 1.91 1.81 1.86 1.86 317,216
Aug 5, 2026 1.90 1.98 1.86 1.87 1.87 1,100,398
Aug 4, 2026 1.75 1.91 1.72 1.87 1.87 808,965
Aug 3, 2026 1.78 1.82 1.71 1.72 1.72 460,199
Jul 31, 2026 1.81 1.81 1.70 1.75 1.75 353,013
Jul 30, 2026 1.72 1.79 1.72 1.77 1.77 389,206
Jul 29, 2026 1.67 1.75 1.67 1.70 1.70 567,922
Jul 28, 2026 1.67 1.70 1.55 1.69 1.69 719,386
Jul 27, 2026 1.69 1.72 1.63 1.67 1.67 499,659
Jul 24, 2026 1.74 1.76 1.64 1.66 1.66 1,034,233
Jul 23, 2026 1.70 1.76 1.69 1.75 1.75 630,752
Jul 22, 2026 1.72 1.76 1.72 1.74 1.74 317,361
Jul 21, 2026 1.72 1.77 1.69 1.75 1.75 364,432
Jul 20, 2026 1.70 1.74 1.66 1.69 1.69 620,244
Jul 17, 2026 1.71 1.78 1.70 1.74 1.74 624,199
Jul 16, 2026 1.77 1.80 1.72 1.74 1.74 475,805
Jul 15, 2026 1.72 1.82 1.71 1.80 1.80 465,300
Jul 14, 2026 1.75 1.75 1.68 1.71 1.71 1,591,488
Jul 13, 2026 1.85 1.85 1.72 1.76 1.76 969,196
Jul 10, 2026 1.93 1.98 1.82 1.86 1.86 1,166,682
Jul 9, 2026 2.00 2.02 1.91 1.95 1.95 1,048,528
Jul 8, 2026 2.00 2.17 1.93 1.99 1.99 1,794,140
Jul 7, 2026 1.96 2.15 1.92 1.92 1.92 1,628,090
Jul 6, 2026 1.96 1.99 1.91 1.97 1.97 456,575
Jul 2, 2026 1.93 2.02 1.89 1.93 1.93 958,352
Jul 1, 2026 1.88 1.96 1.87 1.92 1.92 716,347
Jun 30, 2026 1.88 1.93 1.83 1.86 1.86 667,873
Jun 29, 2026 1.72 1.90 1.71 1.86 1.86 892,556
Jun 26, 2026 1.66 1.72 1.65 1.72 1.72 1,364,405
Jun 25, 2026 1.74 1.74 1.65 1.65 1.65 1,200,240
Jun 24, 2026 1.75 1.78 1.69 1.70 1.70 755,955
Jun 23, 2026 1.72 1.79 1.71 1.74 1.74 670,768
Jun 22, 2026 1.78 1.84 1.73 1.77 1.77 815,599
Jun 18, 2026 1.76 1.80 1.75 1.75 1.75 1,091,219
Jun 17, 2026 1.81 1.90 1.74 1.74 1.74 953,632
Jun 16, 2026 1.78 1.85 1.77 1.79 1.79 670,957
Jun 15, 2026 1.80 1.87 1.77 1.78 1.78 740,839
Jun 12, 2026 1.85 1.90 1.78 1.78 1.78 628,658
Jun 11, 2026 1.71 1.84 1.70 1.83 1.83 1,093,919
Jun 10, 2026 1.76 1.86 1.72 1.72 1.72 1,119,969
Jun 9, 2026 1.78 1.84 1.71 1.77 1.77 1,196,305
Jun 8, 2026 1.92 1.95 1.77 1.79 1.79 931,332
Jun 5, 2026 1.94 1.96 1.85 1.89 1.89 1,403,478
Jun 4, 2026 1.90 2.06 1.86 1.99 1.99 2,035,920
Jun 3, 2026 1.84 1.88 1.79 1.85 1.85 693,933
Jun 2, 2026 1.94 1.94 1.78 1.86 1.86 1,519,541
Jun 1, 2026 1.92 1.96 1.79 1.82 1.82 1,712,517
May 29, 2026 1.90 1.97 1.89 1.92 1.92 960,231
May 28, 2026 2.00 2.01 1.90 1.90 1.90 965,289
May 27, 2026 2.05 2.12 1.98 2.01 2.01 1,180,814
May 26, 2026 2.27 2.33 2.05 2.06 2.06 1,537,440
May 22, 2026 2.25 2.38 2.20 2.23 2.23 2,606,750
May 21, 2026 1.98 2.21 1.91 2.15 2.15 1,237,889
May 20, 2026 1.80 2.04 1.75 2.04 2.04 3,943,171
May 19, 2026 2.01 2.04 1.93 1.94 1.94 1,225,694
May 18, 2026 2.09 2.14 2.01 2.05 2.05 769,700
May 15, 2026 2.03 2.10 2.01 2.06 2.06 854,584
May 14, 2026 2.20 2.22 2.07 2.13 2.13 732,137
May 13, 2026 2.30 2.34 2.22 2.22 2.22 656,479
May 12, 2026 2.36 2.43 2.27 2.28 2.28 679,282
May 11, 2026 2.30 2.47 2.26 2.39 2.39 861,254
May 8, 2026 2.30 2.35 2.25 2.28 2.28 739,646
May 7, 2026 2.40 2.44 2.25 2.26 2.26 906,848
May 6, 2026 2.30 2.42 2.20 2.40 2.40 725,479
May 5, 2026 2.29 2.38 2.19 2.27 2.27 1,761,195
May 4, 2026 2.00 2.35 1.98 2.28 2.28 1,985,813
May 1, 2026 2.01 2.02 1.94 2.00 2.00 708,087
Apr 30, 2026 1.94 2.00 1.86 1.97 1.97 1,104,533
Apr 29, 2026 1.90 1.90 1.79 1.84 1.84 653,034
Apr 28, 2026 1.89 2.00 1.85 1.85 1.85 1,344,365
Apr 27, 2026 1.78 1.94 1.75 1.89 1.89 1,038,587
Apr 24, 2026 1.73 1.82 1.73 1.74 1.74 872,070
Apr 23, 2026 1.82 1.84 1.73 1.81 1.81 1,119,200
Apr 22, 2026 1.89 1.91 1.81 1.84 1.84 811,027
Apr 21, 2026 1.90 1.97 1.85 1.86 1.86 901,936
Apr 20, 2026 1.86 1.95 1.81 1.92 1.92 903,518
Apr 17, 2026 1.82 1.92 1.77 1.87 1.87 1,078,173
Apr 16, 2026 1.77 1.80 1.70 1.78 1.78 851,646
Apr 15, 2026 1.77 1.79 1.70 1.76 1.76 991,332
Apr 14, 2026 1.71 1.73 1.65 1.73 1.73 1,709,407
Apr 13, 2026 1.58 1.71 1.55 1.66 1.66 2,496,057
Apr 10, 2026 1.64 1.64 1.54 1.59 1.59 2,633,156
Apr 9, 2026 1.93 1.98 1.61 1.62 1.62 6,674,479
Apr 8, 2026 2.37 2.42 2.27 2.30 2.30 300,748
Apr 7, 2026 2.33 2.41 2.22 2.27 2.27 647,952
Apr 6, 2026 2.54 2.77 2.33 2.35 2.35 1,349,870
Apr 2, 2026 2.06 2.29 2.03 2.28 2.28 962,628
Apr 1, 2026 2.28 2.29 2.00 2.12 2.12 480,941
Mar 31, 2026 2.03 2.27 2.03 2.23 2.23 467,479
Mar 30, 2026 2.03 2.05 1.96 2.01 2.01 360,422
Mar 27, 2026 2.15 2.16 1.97 2.03 2.03 721,490
Mar 26, 2026 2.20 2.24 2.11 2.15 2.15 452,756
Mar 25, 2026 2.40 2.44 2.21 2.22 2.22 533,720
Mar 24, 2026 2.42 2.48 2.37 2.37 2.37 318,506
Mar 23, 2026 2.62 2.65 2.42 2.50 2.50 345,852
Mar 20, 2026 2.64 2.72 2.51 2.60 2.60 746,179
Mar 19, 2026 2.48 2.67 2.28 2.67 2.67 622,825
Mar 18, 2026 2.72 2.75 2.45 2.47 2.47 658,290
Mar 17, 2026 2.85 3.03 2.70 2.74 2.74 365,368
Mar 16, 2026 2.54 2.90 2.54 2.83 2.83 670,460
Mar 13, 2026 2.44 2.56 2.44 2.52 2.52 236,997
Mar 12, 2026 2.50 2.57 2.43 2.46 2.46 235,370
Mar 11, 2026 2.60 2.68 2.44 2.50 2.50 436,275
Mar 10, 2026 2.62 2.71 2.56 2.58 2.58 225,166
Mar 9, 2026 2.49 2.58 2.41 2.57 2.57 400,289
Mar 6, 2026 2.51 2.55 2.45 2.49 2.49 171,316
Mar 5, 2026 2.61 2.67 2.42 2.48 2.48 250,657
Mar 4, 2026 2.62 2.73 2.56 2.70 2.70 334,634
Mar 3, 2026 2.67 2.67 2.53 2.58 2.58 176,106
Mar 2, 2026 2.51 2.76 2.50 2.67 2.67 435,346
Feb 27, 2026 2.75 2.84 2.64 2.68 2.68 262,386
Feb 26, 2026 2.91 2.94 2.72 2.77 2.77 356,407
Feb 25, 2026 2.80 3.00 2.70 2.88 2.88 779,630
Feb 24, 2026 2.39 2.78 2.38 2.68 2.68 714,296
Feb 23, 2026 2.41 2.47 2.35 2.39 2.39 211,245
Feb 20, 2026 2.36 2.53 2.36 2.48 2.48 348,997
Feb 19, 2026 2.41 2.44 2.36 2.41 2.41 166,236
Feb 18, 2026 2.39 2.51 2.35 2.43 2.43 209,306
Feb 17, 2026 2.35 2.41 2.28 2.38 2.38 339,634
Feb 13, 2026 2.46 2.55 2.37 2.37 2.37 216,558
Feb 12, 2026 2.50 2.65 2.34 2.43 2.43 510,249
Feb 11, 2026 2.46 2.46 2.29 2.37 2.37 265,839
Feb 10, 2026 2.43 2.50 2.39 2.40 2.40 247,387
Feb 9, 2026 2.56 2.56 2.38 2.49 2.49 301,118
Feb 6, 2026 2.54 2.61 2.46 2.49 2.49 550,923
Feb 5, 2026 2.55 2.62 2.42 2.44 2.44 345,612
Feb 4, 2026 2.63 2.73 2.45 2.58 2.58 465,110
Feb 3, 2026 2.71 2.81 2.55 2.60 2.60 250,814
Feb 2, 2026 2.66 2.79 2.65 2.70 2.70 246,190
Jan 30, 2026 2.80 2.88 2.60 2.70 2.70 534,152
Jan 29, 2026 2.90 2.96 2.75 2.81 2.81 481,577
Jan 28, 2026 2.91 3.14 2.91 3.04 3.04 457,349
Jan 27, 2026 2.93 3.02 2.80 2.90 2.90 409,783
Jan 26, 2026 3.01 3.01 2.83 2.96 2.96 494,467
Jan 23, 2026 3.02 3.06 2.92 3.01 3.01 313,604
Jan 22, 2026 2.93 3.19 2.93 3.06 3.06 754,783
Jan 21, 2026 2.79 2.92 2.78 2.88 2.88 419,810
Jan 20, 2026 2.77 2.87 2.70 2.79 2.79 649,866
Jan 16, 2026 3.25 3.26 2.88 2.89 2.89 835,506
Jan 15, 2026 3.15 3.30 3.10 3.20 3.20 366,239
Jan 14, 2026 3.07 3.23 2.98 3.17 3.17 559,422
Jan 13, 2026 3.49 3.53 3.00 3.12 3.12 1,205,875
Jan 12, 2026 3.60 3.61 3.31 3.45 3.45 826,573
Jan 9, 2026 3.97 4.02 3.66 3.67 3.67 397,911
Jan 8, 2026 4.04 4.14 3.90 3.92 3.92 296,019
Jan 7, 2026 3.89 4.12 3.88 4.07 4.07 654,834
Jan 6, 2026 3.81 3.94 3.75 3.85 3.85 443,953
Jan 5, 2026 3.70 3.83 3.60 3.80 3.80 496,998
Jan 2, 2026 3.45 3.68 3.26 3.65 3.65 469,662
Dec 31, 2025 3.44 3.50 3.36 3.46 3.46 354,824
Dec 30, 2025 3.48 3.64 3.43 3.46 3.46 339,240
Dec 29, 2025 3.52 3.71 3.50 3.50 3.50 287,273
Dec 26, 2025 3.61 3.72 3.49 3.60 3.60 286,933
Dec 24, 2025 3.58 3.69 3.56 3.66 3.66 130,813
Dec 23, 2025 3.89 3.91 3.57 3.58 3.58 526,547
Dec 22, 2025 3.74 4.04 3.60 3.93 3.93 628,081
Dec 19, 2025 3.68 3.74 3.46 3.65 3.65 873,645
Dec 18, 2025 3.69 3.86 3.65 3.67 3.67 603,857
Dec 17, 2025 3.93 4.04 3.58 3.62 3.62 609,536
Dec 16, 2025 3.71 3.99 3.71 3.93 3.93 415,406
Dec 15, 2025 4.15 4.24 3.76 3.78 3.78 712,792
Dec 12, 2025 3.77 4.23 3.70 4.13 4.13 1,044,279
Dec 11, 2025 4.12 4.15 3.70 3.79 3.79 1,487,011
Dec 10, 2025 4.45 4.57 4.18 4.20 4.20 778,653
Dec 9, 2025 4.50 4.64 4.34 4.46 4.46 717,325
Dec 8, 2025 4.48 4.55 4.12 4.30 4.30 937,974
Dec 5, 2025 4.66 4.76 4.40 4.55 4.55 604,031
Dec 4, 2025 4.68 4.82 4.60 4.65 4.65 499,687
Dec 3, 2025 4.35 4.76 4.32 4.65 4.65 1,358,085
Dec 2, 2025 4.46 4.71 4.01 4.41 4.41 1,604,082
Dec 1, 2025 5.04 5.09 4.32 4.51 4.51 1,854,721
Nov 28, 2025 5.05 5.50 4.90 5.10 5.10 1,291,769
Nov 26, 2025 5.02 5.25 4.57 4.92 4.92 2,925,555
Nov 25, 2025 4.08 4.83 4.01 4.82 4.82 2,367,455
Nov 24, 2025 3.84 4.48 3.82 4.09 4.09 3,310,690
Nov 21, 2025 3.91 4.00 3.47 3.79 3.79 1,969,291
Nov 20, 2025 3.44 3.98 3.39 3.88 3.88 3,595,932
Nov 19, 2025 3.51 3.69 3.25 3.38 3.38 2,411,716
Nov 18, 2025 2.98 3.82 2.98 3.37 3.37 7,205,610
Nov 17, 2025 2.37 4.00 2.36 3.03 3.03 44,362,601
Nov 14, 2025 2.11 2.42 2.11 2.34 2.34 617,691
Nov 13, 2025 2.38 2.43 2.23 2.29 2.29 555,866
Nov 12, 2025 2.17 2.49 2.17 2.43 2.43 1,712,886
Nov 11, 2025 2.00 2.11 1.96 2.11 2.11 168,835
Nov 10, 2025 2.08 2.08 1.96 1.99 1.99 114,667
Nov 7, 2025 1.91 2.05 1.90 2.00 2.00 242,361
Nov 6, 2025 2.05 2.08 1.92 1.99 1.99 192,210
Nov 5, 2025 1.92 2.17 1.90 2.04 2.04 220,525
Nov 4, 2025 1.95 2.03 1.89 1.89 1.89 246,609
Nov 3, 2025 2.08 2.09 1.95 2.02 2.02 275,154
Oct 31, 2025 2.08 2.15 2.03 2.10 2.10 174,098
Oct 30, 2025 2.19 2.25 2.07 2.08 2.08 202,506
Oct 29, 2025 2.08 2.29 2.08 2.20 2.20 724,476
Oct 28, 2025 2.12 2.14 2.07 2.10 2.10 257,893
Oct 27, 2025 2.11 2.24 2.06 2.15 2.15 1,339,610
Oct 24, 2025 2.05 2.07 2.02 2.05 2.05 267,970
Oct 23, 2025 2.00 2.08 2.00 2.02 2.02 138,858
Oct 22, 2025 2.10 2.15 1.97 2.03 2.03 477,667
Oct 21, 2025 2.10 2.23 2.01 2.17 2.17 820,076
Oct 20, 2025 1.90 2.08 1.90 2.07 2.07 529,916
Oct 17, 2025 1.99 2.06 1.94 1.98 1.98 476,014
Oct 16, 2025 1.89 2.21 1.88 2.03 2.03 2,936,337
Oct 15, 2025 1.62 1.85 1.62 1.81 1.81 857,553
Oct 14, 2025 1.61 1.72 1.60 1.68 1.68 662,400
Oct 13, 2025 1.74 1.76 1.57 1.66 1.66 1,447,619
Oct 10, 2025 1.61 1.80 1.60 1.70 1.70 7,805,969
Oct 9, 2025 2.49 2.60 2.11 2.20 2.20 8,697,957
Oct 8, 2025 2.25 2.29 2.22 2.27 2.27 228,522
Oct 7, 2025 2.27 2.29 2.24 2.26 2.26 182,239
Oct 6, 2025 2.20 2.28 2.20 2.26 2.26 326,032
Oct 3, 2025 2.23 2.28 2.19 2.22 2.22 210,880
Oct 2, 2025 2.17 2.23 2.13 2.23 2.23 229,875
Oct 1, 2025 2.02 2.15 2.02 2.13 2.13 294,875
Sep 30, 2025 2.04 2.07 2.01 2.07 2.07 133,804
Sep 29, 2025 2.01 2.06 2.00 2.04 2.04 175,365
Sep 26, 2025 2.16 2.17 1.88 1.97 1.97 770,321
Sep 25, 2025 2.20 2.20 2.08 2.13 2.13 201,147
Sep 24, 2025 2.20 2.28 2.16 2.19 2.19 136,321

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Annovis Bio, Inc. Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at ANVS, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation